These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The adjuvant effect of powdered ferric oxide: enhancement of response to Mycoplasma pneumoniae and respiratory syncytial virus vaccines. Warren J; Kende M; Takano K J Immunol; 1969 May; 102(5):1300-8. PubMed ID: 4976970 [No Abstract] [Full Text] [Related]
6. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Fulginiti VA; Eller JJ; Sieber OF; Joyner JW; Minamitani M; Meiklejohn G Am J Epidemiol; 1969 Apr; 89(4):435-48. PubMed ID: 4305199 [No Abstract] [Full Text] [Related]
7. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Chin J; Magoffin RL; Shearer LA; Schieble JH; Lennette EH Am J Epidemiol; 1969 Apr; 89(4):449-63. PubMed ID: 4305200 [No Abstract] [Full Text] [Related]
8. Respiratory virus vaccines. VII. Field evaluation of respiratory syncytial, parainfluenza 1, 2, 3, and Mycoplasma pneumoniae vaccines, 1965 to 1966. Weibel RE; Stokes J; Leagus MB; Mascoli CC; Tytell AA; Woodhour AF; Vella PP; Hilleman MR Am Rev Respir Dis; 1967 Oct; 96(4):724-39. PubMed ID: 4293644 [No Abstract] [Full Text] [Related]
10. Serologic profile of children in a Mexican highland community: prevalence of complement-fixing antibodies to Mycoplasma pneumoniae, respiratory syncytial virus and parainfluenza viruses. Golubjatnikov R; Allen VD; Olmos-Blancarte MP; Inhorn SL Am J Epidemiol; 1975 May; 101(5):458-64. PubMed ID: 165720 [TBL] [Abstract][Full Text] [Related]
11. Respiratory virus vaccines. VI. Serologic responses to heptavalent vaccine among young children in families. Leagus MB; Weibel RE; Mascoli CC; Stokes J; Hilleman MR Am Rev Respir Dis; 1967 May; 95(5):838-44. PubMed ID: 4290291 [No Abstract] [Full Text] [Related]
12. A variant of parainfluenza type 2 virus. Numazaki Y; Shigeta S; Yano N; Takai S; Ishida N Proc Soc Exp Biol Med; 1968 Apr; 127(4):992-6. PubMed ID: 4297701 [No Abstract] [Full Text] [Related]
13. The role of the secretory immune system in protection against agents which infect the respiratory tract. Waldman RH; Ganguly R Adv Exp Med Biol; 1974; 45(0):283-94. PubMed ID: 4370501 [No Abstract] [Full Text] [Related]
14. [Viral etiology of acute pneumonias in children and some of their epidemiological patterns in Kirghizia]. Evdoshenko VG; Kolodin AV; Vorob'eva LM; Pokrovskaia TI; Abdykadyrova DD Vopr Virusol; 1973; 18(6):670-6. PubMed ID: 4364049 [No Abstract] [Full Text] [Related]
15. Antibodies to viruses of human origin in monkeys from Uganda. Mutanda LN; Mufson MA Proc Soc Exp Biol Med; 1974 Mar; 145(3):1069-73. PubMed ID: 4362003 [No Abstract] [Full Text] [Related]
16. [Antibody complement fixation for respiratory syncytial virus and adenovirus and hemagglutination inhibition of para-influenza viruses 1, 2 and 3 in a Brazilian children population]. Candeias JA Rev Saude Publica; 1968 Jun; 2(1):44-67. PubMed ID: 4313546 [No Abstract] [Full Text] [Related]
18. The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. Cooney MK; Fox JP; Hall CE Am J Epidemiol; 1975 Jun; 101(6):532-51. PubMed ID: 168766 [TBL] [Abstract][Full Text] [Related]